The St. Jude-Washington University Pediatric Cancer Genome Project is a collaborative effort between researchers at St. Jude Children's Research Hospital and the Washington University School of Medicine. The project involves analyzing the genomes of over 600 pediatric cancer patients to understand how some aggressive forms of childhood cancer develop. Researchers compare the genomes of normal and cancer cells to pinpoint differences in DNA and determine which disparities are linked to cancer. Data from the project is posted online.

1. St. Jude-Washington University
Pediatric Cancer Genome Project

2. A philanthropist, entrepreneur, and financial
professional, Derek Dewan is the founder of
several businesses and former chairman of
the board at MPS Group, Inc. He helped
organize the $1.3 billion sale of the MPS
Group. Derek Dewan also contributes to St.
Jude Children's Research Hospital as a
member of the Professional Advisory Board
for ALSAC, the hospital's fundraising division.

3. At St. Jude Children's Research Hospital,
specialists provide expert care and
treatments and conduct research that
changes of landscape of health science.

4. The Pediatric Cancer Genome Project is just one of
the projects underway at the hospital. Researchers
from St. Jude and the Washington University School
of Medicine formed a collaborative effort to analyze
genomes from over 600 patients to understand how
some of the most aggressive forms of childhood
cancer originate. The process involves comparing
the genomes from normal cells and cancer cells.
Scientists are attempting to pinpoint exact
differences in DNA and determine which disparities
have links to cancer. Data from the project is posted
at www.explore.pediatriccancergenomeproject.org.